Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Triazolopyridine antiplatelet agents in the pipeline at Ortho-McNeil

March 13, 2000

BTG outlicenses factor IX gene to Avigen

March 9, 2000

FDA approves ReFacto for hemophilia A

March 8, 2000

Potent factor XIIIa inhibitor synthesized from naturally occurring cyclopropenones

March 3, 2000

Neutralase effectively reverses new anticoagulants

March 2, 2000

Antiplatelet agents under study at Chinese centers

Feb. 25, 2000

Orally active antiplatelet agents in development at Lafon

Feb. 24, 2000

Approvable letter issued by FDA for Texas Biotechnology's Novastan

Feb. 23, 2000

Immune Response synthesizes new factor VIII gene

Feb. 23, 2000

Lafon presents piperazinone-based antithrombotic agents

Feb. 22, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld
Hematopoietic stem cell research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...